ASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myelomaDecember 7, 2014Multiple Myeloma
FDA extends review of panobinostat for combination treatment of multiple myelomaDecember 1, 2014Multiple Myeloma
